Skip to main content

Table 3 KD patients with fever duration of 5 or 6 days in the both groups (n = 204)

From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea

  2000–2004 (n = 100) 2010–2014 (n = 104) P
Age (month) 31.1 ± 22 31 ± 20.1 0.978
Sex (M/F) 56/44 64/40 0.477
Fever duration (day)
 Preadmission 5.4 ± 0.5 5.3 ± 0.4 0.047
 Total 7.1 ± 1.8 6.8 ± 1.5 0.104
Hospitalization (day) 8.6 ± 2.8 5.8 ± 1.8 < 0.001
Incomplete KD, n (%) 22 (22) 46 (44.2) 0.001
Repeated IVIG, n (%) 7 (7) 10 (9.6) 0.615
CALs, n (%) 31(31) 17 (16.3) 0.020
Eectasia 29 (29) 17 (16.3) 0.044
Aneurysm 2 (2) 0 (0) 0.239
WBC (/mm3) 15,500 ± 4800 14,800 ± 5100 0.318
 Neutrophil (%) 65.7 ± 13.7 66.8 ± 15.0 0.572
 Lymphocyte (%) 21.8 ± 11.7 23.2 ± 12.6 0.407
Hemoglobin (g/dL) 10.7 ± 0.8 11.4 ± 0.9 < 0.001
Platelet (x-103/mm3) 323 ± 125 317 ± 78 0.038
Platelet, follow-up 532 ± 168 407 ± 120 < 0.001
CRP (mg/dL) 12.5 ± 7.1 9.3 ± 6.1 0.001
ESR (mm/h) 58 ± 24 77 ± 39 < 0.001
Total protein (g/dL) 6.4 ± 0.6 6.4 ± 0.6 0.848
Albumin (g/dL) 3.5 ± 0.4 3.7 ± 0.4 0.002
AST (IU/L) 59 ± 90 71 ± 110 0.397
ALT (IU/L) 102 ± 125 114 ± 177 0.570
ALT <40 IU, n (%) 46 (46) 43 (41.3) 0.573
ALT 41–99 IU, n (%) 23 (23) 33 (31.7) 0.209
ALT >100 IU, n (%) 31 (31) 28 (26.9) 0.540
  1. Values are mean ± SD or n (%). Abbreviations as in Table 1